
Vivo Bio Tech Ltd. is Rated Strong Sell
2026-03-18 10:11:11Vivo Bio Tech Ltd. is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 18 March 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Vivo Bio Tech Ltd. Stock Hits 52-Week Low Amidst Continued Downtrend
2026-03-11 14:08:10Shares of Vivo Bio Tech Ltd. touched a fresh 52-week low of Rs.23 today, marking a significant decline amid persistent downward momentum. The stock has underperformed its sector and broader market indices, reflecting ongoing concerns about its financial health and market positioning.
Read full news article
Vivo Bio Tech Ltd. is Rated Strong Sell
2026-03-05 10:10:53Vivo Bio Tech Ltd. is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 05 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.
Read full news article
Vivo Bio Tech Ltd. Stock Hits 52-Week Low at Rs.24.52
2026-03-04 12:46:56Vivo Bio Tech Ltd., a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.24.52 today, marking a significant decline amid persistent downward momentum. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its financial and market performance.
Read full news article
Vivo Bio Tech Ltd. is Rated Strong Sell
2026-02-17 10:10:54Vivo Bio Tech Ltd. is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 17 February 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and technical outlook.
Read full news article
Vivo Bio Tech Ltd. is Rated Strong Sell
2026-02-03 10:16:54Vivo Bio Tech Ltd. is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 February 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Vivo Bio Tech Ltd. Stock Hits 52-Week Low Amidst Continued Downtrend
2026-02-02 11:22:50Vivo Bio Tech Ltd., a player in the Pharmaceuticals & Biotechnology sector, recorded a fresh 52-week low of Rs.25.2 today, marking a significant decline in its stock price amid a broader market environment showing mixed signals. The stock’s performance reflects ongoing pressures, with a notable underperformance relative to its sector and benchmark indices.
Read full news article
Vivo Bio Tech Ltd. Downgraded to Strong Sell Amid Weak Fundamentals and Bearish Technicals
2026-01-20 08:12:47Vivo Bio Tech Ltd., a player in the Pharmaceuticals & Biotechnology sector, has been downgraded from a Sell to a Strong Sell rating as of 19 Jan 2026. This revision reflects deteriorating technical indicators, stagnant financial trends, weak quality metrics, and a valuation that, while attractive, is overshadowed by the company’s faltering fundamentals and poor market performance relative to benchmarks like the Sensex.
Read full news article
Vivo Bio Tech Ltd. is Rated Strong Sell
2026-01-07 10:10:55Vivo Bio Tech Ltd. is rated Strong Sell by MarketsMOJO, with this rating last updated on 24 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 January 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news articleAnnouncement under Regulation 30 (LODR)-Newspaper Publication
16-Feb-2026 | Source : BSENewspaper publication for financial results
Un-Audited Standalone & Consolidated Financial Results Of The Company For The Third Quarter And Nine Months Ended December 31 2025
13-Feb-2026 | Source : BSEplease find enclosed
Board Meeting Outcome for Un-Audited Standalone & Consolidated Financial Results Of The Company For The Third Quarter And Nine Months Ended December 31 2025
13-Feb-2026 | Source : BSEplease find enclosed
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






